Related references
Note: Only part of the references are listed.Toward Combined Cell and Gene Therapy for Genodermatoses
Laura De Rosa et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2020)
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility
C. Has et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations
Andrew Kwong et al.
MOLECULAR THERAPY (2020)
Emergency management in epidermolysis bullosa: consensus clinical recommendations from the European reference network for rare skin diseases
Jemima E. Mellerio et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Epidermolysis bullosa
Ajoy Bardhan et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Attenuation of Severe Generalized Junctional Epidermolysis Bullosa by Systemic Treatment with Gentamicin
Johanna Hammersen et al.
DERMATOLOGY (2019)
Advances in stem cell research and therapeutic development
Michele De Luca et al.
NATURE CELL BIOLOGY (2019)
Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa
Shaundra Eichstadt et al.
JCI INSIGHT (2019)
Newer Treatment Modalities in Epidermolysis Bullosa
Leena Bruckner-Tuderman
INDIAN DERMATOLOGY ONLINE JOURNAL (2019)
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells
Johann W. Bauer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Regeneration of the entire human epidermis using transgenic stem cells
Tobias Hirsch et al.
NATURE (2017)
Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa
Zurab Siprashvili et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis Bullosa
Johanna Hammersen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases
H. Montaudie et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Pain care for patients with epidermolysis bullosa: best care practice guidelines
Kenneth R. Goldschneider et al.
BMC MEDICINE (2014)
Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)
Clement C. H. Loh et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
Jo-David Fine et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Long-Term Stability and Safety of Transgenic Cultured Epidermal Stem Cells in Gene Therapy of Junctional Epidermolysis Bullosa
Laura De Rosa et al.
STEM CELL REPORTS (2014)
Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes
A. Cavazza et al.
GENE THERAPY (2013)
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells
Graziella Pellegrini et al.
REGENERATIVE MEDICINE (2013)
Laminin 332 in junctional epidermolysis bullosa
Dimitra Kiritsi et al.
CELL ADHESION & MIGRATION (2013)
Squamous cell carcinoma and junctional epidermolysis bullosa
Jo-David Fine
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: Report of 7 cases and a review of the literature
Wing Yan Yuen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity
Chuanfeng Wu et al.
Frontiers of Medicine (2011)
Long-Term Type VII Collagen Restoration to Human Epidermolysis Bullosa Skin Tissue
Zurab Siprashvili et al.
HUMAN GENE THERAPY (2010)
Inherited epidermolysis bullosa
Jo-David Fine
ORPHANET JOURNAL OF RARE DISEASES (2010)
Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument
J. W. Frew et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006
Jo-David Fine et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Cause-specific risks of childhood death in inherited epidermolysis bullosa
Jo-David Fine et al.
JOURNAL OF PEDIATRICS (2008)
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells
Fulvio Mavilio et al.
NATURE MEDICINE (2006)
Regeneration of squamous epithelia from stem cells of cultured grafts
Michele De Luca et al.
REGENERATIVE MEDICINE (2006)
Hematopoietic stem cell transplantation and subsequent 80% skin exchange by grafts from the same donor in a patient with Herlitz disease
J Kopp et al.
TRANSPLANTATION (2005)
Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa
R Maltipeddi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2004)
Analysis of the LAMB3 gene in a junctional epidermolysis bullosa patient reveals exonic splicing and allele-specific nonsense-mediated mRNA decay
B Buchroithner et al.
LABORATORY INVESTIGATION (2004)
Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa
P Posteraro et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Share Paper
